Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02900976 |
|---|---|
| Brief Title: | Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder |
| First Submitted : | September 6, 2016 |
| First Submitted that Met QC Criteria : | September 9, 2016 |
| First Posted : | September 15, 2016 (Estimate) |
| Results First Submitted : | March 4, 2022 |
| Results First Posted with QC Comments : | March 31, 2022 |
| Results First Submitted that Met QC Criteria : | June 2, 2022 |
| Results First Posted : | June 3, 2022 |
| Last Update Submitted that Met QC Criteria : | June 2, 2022 |
| Last Update Posted : | June 3, 2022 |